Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 5, 2013, Pages

  King, Paul T ^a,b   Lim, Steven ^a   Pick, Adrian ^a,c   Ngui, James ^b   Prodanovic, Zdenka ^d   Downey, William ^c   Choong, Cliff ^a   Kelman, Anthony ^e   Baranyai, Elizabeth ^c   Francis, Michelle ^e   Moshinsky, Randall ^a   Bardin, Philip G ^b   Holmes, Peter W ^b   Holdsworth, Stephen R ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c CABRINI HOSPITAL   (Australia)

^d MMC Southern Health   (Australia)

^e MMC   (Australia)

Author keywords

bacteria; chronic obstructive pulmonary disease; inflammation; T cell

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOBECTOMY; LUNG CANCER; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; T LYMPHOCYTE;

EID: 84876913148     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.09.030     Document Type: Article

References (47)

1. The top 10 causes of death 2008 World Health Organization Geneva (Switzerland)
2. J.B. Soriano, and R. Rodriguez-Roisin Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation Proc Am Thorac Soc 8 2011 363 367
3. S.D. Shapiro End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on Am J Respir Crit Care Med 164 2001 339 340
4. A.G. Drannik, M.A. Pouladi, C.S. Robbins, S.I. Goncharova, S. Kianpour, and M.R. Stampfli Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection Am J Respir Crit Care Med 170 2004 1164 1171
5. P. Marti-Lliteras, V. Regueiro, P. Morey, D.W. Hood, C. Saus, and J. Sauleda Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke Infect Immun 77 2009 4232 4242
6. G.J. Gaschler, M. Skrtic, C.C. Zavitz, M. Lindahl, P.O. Onnervik, and T.F. Murphy Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile Am J Respir Crit Care Med 179 2009 666 675
7. J.C. Hogg, F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, and L. Buzatu The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653
8. A.K. Sullivan, P.L. Simonian, M.T. Falta, J.D. Mitchell, G.P. Cosgrove, and K.K. Brown Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema Am J Respir Crit Care Med 172 2005 590 596
9. G.G. Brusselle, T. Demoor, K.R. Bracke, C.A. Brandsma, and W. Timens Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur Respir J 34 2009 219 230
10. M.R. Stampfli, and G.P. Anderson How cigarette smoke skews immune responses to promote infection, lung disease and cancer Nat Rev Immunol 9 2009 377 384
11. M.G. Cosio, M. Saetta, and A. Agusti Immunologic aspects of chronic obstructive pulmonary disease N Engl J Med 360 2009 2445 2454
12. V. Bandi, M.A. Apicella, E. Mason, T.F. Murphy, A. Siddiqi, and R.L. Atmar Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis Am J Respir Crit Care Med 164 2001 2114 2119
13. V. Bandi, M. Jakubowycz, C. Kinyon, E.O. Mason, R.L. Atmar, and S.B. Greenberg Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae FEMS Immunol Med Microbiol 37 2003 69 75
14. A. Rosell, E. Monso, N. Soler, F. Torres, J. Angrill, and G. Riise Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease Arch Intern Med 165 2005 891 897
15. T.F. Murphy, A.L. Brauer, A.T. Schiffmacher, and S. Sethi Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 266 272
16. K.H. Groenewegen, and E.F. Wouters Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study Respir Med 97 2003 770 777
17. A.T. Hill, E.J. Campbell, S.L. Hill, D.L. Bayley, and R.A. Stockley Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis Am J Med 109 2000 288 295
18. I.S. Patel, T.A. Seemungal, M. Wilks, S.J. Lloyd-Owen, G.C. Donaldson, and J.A. Wedzicha Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations Thorax 57 2002 759 764
19. L.V. Moller, W. Timens, W. van der Bij, K. Kooi, B. de Wever, and J. Dankert Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease Am J Respir Crit Care Med 157 1998 950 956
20. D. Dromann, J. Rupp, K. Rohmann, S. Osbahr, A.J. Ulmer, and S. Marwitz The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae Respir Res 11 2010 67
21. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
22. P. King, J. Ngui, M. Farmer, P. Hutchinson, P. Holmes, and S. Holdsworth Cytotoxic T cell and natural killer cell responses to nontypeable Haemophilus influenzae Clin Exp Immunol 152 2008 542 551
23. P.T. King, P.E. Hutchinson, P.D. Johnson, P.W. Holmes, N.J. Freezer, and S.R. Holdsworth Adaptive immunity to nontypeable Haemophilus influenzae Am J Respir Crit Care Med 167 2003 587 592
24. J.C. Hogg Pathophysiology of airflow limitation in chronic obstructive pulmonary disease Lancet 364 2004 709 721
25. S.H. Lee, S. Goswami, A. Grudo, L.Z. Song, V. Bandi, and S. Goodnight-White Antielastin autoimmunity in tobacco smoking-induced emphysema Nat Med 13 2007 567 569
26. J.V. Gosselink, S. Hayashi, W.M. Elliott, L. Xing, B. Chan, and L. Yang Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 2010 1329 1335
27. K. Murphy, P. Travers, and M. Walport T cell-mediated immunity K. Murphy, P. Travers, M. Walport, Janeway's immunobiology 7th ed. 2008 Garland Science New York 323 372
28. J.A. Elias, M.J. Kang, K. Crothers, R. Homer, and C.G. Lee State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice Proc Am Thorac Soc 3 2006 494 498
29. T.A. Wynn Fibrotic disease and the T(H)1/T(H)2 paradigm Nat Rev Immunol 4 2004 583 594
30. Z. Zhu, R.J. Homer, Z. Wang, Q. Chen, G.P. Geba, and J. Wang Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production J Clin Invest 103 1999 779 788
31. C.M. Lloyd, and E.M. Hessel Functions of T cells in asthma: more than just T(H)2 cells Nat Rev Immunol 10 2010 838 848
32. E. Bettelli, T. Korn, M. Oukka, and V.K. Kuchroo Induction and effector functions of T(H)17 cells Nature 453 2008 1051 1057
33. J.F. Alcorn, C.R. Crowe, and J.K. Kolls TH17 cells in asthma and COPD Annu Rev Physiol 72 2010 495 516
34. A. Gadgil, and S.R. Duncan Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 3 2008 531 541
35. J. Elias The relationship between asthma and COPD. Lessons from transgenic mice Chest 126 2004 111S 1116S discussion 59S-61S
36. G. Hodge, J. Nairn, M. Holmes, P.N. Reynolds, and S. Hodge Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects Clin Exp Immunol 150 2007 22 29
37. T.F. Murphy Haemophilus infections F. Braunwald, D.L. Kaspar, S.L. Hauser, D.L. Longo, L. Jameson, Harrisons principles of internal medicine 15th ed. 2001 McGraw Hill New York 939 942
38. M. Hilty, C. Burke, H. Pedro, P. Cardenas, A. Bush, and C. Bossley Disordered microbial communities in asthmatic airways PLoS one 5 2010 e8578
39. J. Forsgren, A. Samuelson, A. Ahlin, J. Jonasson, B. Rynnel-Dagoo, and A. Lindberg Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay Infect Immun 62 1994 673 679
40. I.L. Ahren, D.L. Williams, P.J. Rice, A. Forsgren, and K. Riesbeck The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells J Infect Dis 184 2001 150 158
41. R.K. Albert, J. Connett, W.C. Bailey, R. Casaburi, J.A. Cooper Jr., and G.J. Criner Azithromycin for prevention of exacerbations of COPD N Engl J Med 365 2011 689 698
42. P. King, J. Ngui, M. Farmer, P. Hutchinson, P. Holmes, and S. Holdsworth Cytotoxic T cell and natural killer cell responses to nontypeable Haemophilus influenzae Clin Exp Immunol 152 2008 542 551
43. P.T. King, P.E. Hutchinson, P.D. Johnson, P.W. Holmes, N.J. Freezer, and S.R. Holdsworth Adaptive immunity to nontypeable Haemophilus influenzae Am J Respir Crit Care Med 167 2003 587 592
44. I.L. Ahren, D.L. Williams, P.J. Rice, A. Forsgren, and K. Riesbeck The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells J Infect Dis 184 2001 150 158
45. J.W. Johnston Laboratory growth and maintenance of Haemophilus influenzae Curr Protoc Microbiol 2010 Chapter 6:Unit 6D 1
46. K. Murphy, P. Travers, and M. Walport T cell-mediated immunity K. Murphy, P. Travers, M. Walport, Janeway's immunobiology 7th ed. 2008 Garland Science New York 323 372
47. W. Strober Trypan blue exclusion test of cell viability Curr Protoc Immunol 2001 Appendix 3:Appendix 3B